GRAIL (GRAL) Stock: Buy, Sell, or Hold?
GRAL - GRAIL, Inc. Common Stock
$75.11
-0.78 (-1.03%)
âŧ
5d:
-3.06%
30d:
+7.38%
90d:
+28.86%
WAIT
LOW Confidence
Analysis Updated: Sep 16, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Get Alerted When GRAL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: GRAL is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: GRAL is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: GRAL is currently trading at $75.11, which is considered fair relative to its 30-day fair value range of $72.37 to $80.71.
Technical Outlook: Technically, GRAL is in a strong uptrend. The price is currently testing key support at $73.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: GRAL scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GRAL is in a strong uptrend. The price is currently testing key support at $73.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: GRAL scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$72.37 -
$80.71
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
44.7%
Protect Your Profits
Holding GRAL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (31/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($77.00)
- WARNING: Composite score 48/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$72.37 -
$80.71
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$73.46
Resistance Level
$83.00
Current Trend
Strong Uptrend
Technical data as of
Sep 16, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.40
Wall Street Target
$77.00
(+2.5%)
Revenue Growth (YoY)
25.7%
Profit Margin
-236.9%
Share & Embed Analysis
Last updated: September 17, 2026 12:42 AM ET
Data refreshes hourly during market hours. Next update: 1:42 AM
Data refreshes hourly during market hours. Next update: 1:42 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GRAL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Joshua J Ofman
SELL
61665 shares
2026-04-08
Robert P Ragusa
SELL
123502 shares
2026-04-08
Aaron Freidin
SELL
45806 shares
2026-04-08
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher ScientificâĻ |
STRONG BUY
31 analysts |
$645 | 47 HOLD |
|
EXAS
EXACT Sciences CorporatiâĻ |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$229 | 53 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$196 | 49 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$344 | 47 HOLD |
Advanced GRAL Option Strategies
Professional options setups generated by AI based on today's GRAL price and gamma walls.
